Varenicline for smoking cessation: A placebo-controlled, randomized study
Background and objective: Varenicline tartrate, a novel, selective, nicotinic acetylcholine receptor partial agonist, has been developed specifically as a smoking cessation drug. This study evaluated the efficacy of a standard regimen of varenicline compared with placebo for smoking cessation in 333...
Saved in:
Main Authors: | Wang C., Xiao D., Chan K.P.W., Pothirat C., Garza D., Davies S. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-63849201453&partnerID=40&md5=7f76200f917f9424248ddfe542380ec8 http://cmuir.cmu.ac.th/handle/6653943832/2874 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Varenicline for smoking cessation: A placebo-controlled, randomized study
by: Chen Wang, et al.
Published: (2018) -
Varenicline for smoking cessation: A placebo-controlled, randomized study
by: Chen Wang, et al.
Published: (2018) -
Clonidine for smoking cessation
by: Arth Nana, et al.
Published: (2018) -
Incentive programmes for smoking cessation: Cluster randomized trial in workplaces in Thailand
by: Justin S. White, et al.
Published: (2020) -
Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials
by: Awirut Oon-arom, et al.
Published: (2020)